A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma

BACKGROUND: The efficacy and/or tolerability of pazopanib in patients with metastatic renal cell carcinoma (mRCC) have been found to differ in Western and Asian populations. This retrospective multicenter study analyzed the results of first-line pazopanib treatment in 93 consecutive patients with mR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Urol
Asıl Yazarlar: Kim, Moon Jin, Park, Se Hoon, Lee, Jae-Lyun, Lee, Se-Hoon, Lee, Su Jin, Lim, Ho Yeong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4970295/
https://ncbi.nlm.nih.gov/pubmed/27484998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0163-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller